OLEMA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.49 USD | +5.58% |
|
+5.85% | -10.98% |
Chart calendar Olema Pharmaceuticals, Inc.
8736c136ab16afc36cd4fab3f7b0.e_-aG51RzKTSCnC8DXow7rA4pDRd4WYOyuXnr1ln1rM.H5jWfsoLp93rcBP4SClB3Px95gw8pQJErq7X4XRetMM5mP9WrB36kINEJQ~5949d4db79d57d44ec17d473f942b8f6
Upcoming events on Olema Pharmaceuticals, Inc.
Past events on Olema Pharmaceuticals, Inc.
| 2024-09-04 07:45 | Morgan Stanley Healthcare Conference - Fireside Chat |
| 2024-08-06 16:02 | Q2 2024 Earnings Release |
| 2024-06-13 11:00 | Annual General Meeting |
| 2024-06-12 11:20 | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2024-06-05 14:00 | Jefferies Global Healthcare Conference - Fireside Chat |
| 2024-05-30 | American Society of Clinical Oncology Meeting |
| 2024-05-28 10:00 | TD Cowen Oncology Innovation Summit - Fireside Chat |
| 2024-05-20 | UBS Spring Biotech Symposium |
| 2024-05-20 16:00 | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
| 2024-05-16 06:00 | ESMO Breast Cancer Congress - Poster Presentation #212P |
| 2024-05-15 08:00 | ESMO Breast Cancer Congress |
| 2024-05-14 19:35 | BofA Securities Health Care Conference |
| 2024-05-08 16:02 | Q1 2024 Earnings Release |
| 2024-04-15 14:00 | CG Horizons in Oncology Virtual Conference - Panel |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 16:03 | Q4 2023 Earnings Release |
| 2024-03-06 09:10 | TD Cowen Health Care Conference - Panel |
| 2024-02-13 10:40 | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 20:15 | JPMorgan Healthcare Conference |
| 2023-12-07 18:30 | San Antonio Breast Cancer Symposium - PS15-04 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 5,84 |
|
EBITDA Million USD | Released Forecast Spread | -71,3 -71,0 -0.46% | -107 -124 14.01% | -105 -98,8 -5.83% | -133 | -180 | -220 |
|
EBIT Million USD | Released Forecast Spread | -71,5 -67,2 -6.42% | -107 -106 -0.77% | -105 -100 -4.78% | -137 | -166 | -191 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -71,1 -66,8 -6.37% | -105 -105 -0.26% | -96,7 -94,0 -2.78% | -130 | -156 | -174 |
|
Net income Million USD | Released Forecast Spread | -71,1 -66,8 -6.37% | -105 -105 0.02% | -96,7 -94,0 -2.83% | -130 | -156 | -174 |
|
EPS USD | Released Forecast Spread | -1,80 -1,68 -7.14% | -2,62 -2,67 1.92% | -2,14 -2,13 -0.34% | -1,51 | -2,57 | -2,79 |
| Announcement Date | 28/02/22 | 09/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -23,1 -35,0 33.91% | -27,1 -24,0 -13.01% | -29,5 -28,0 -5.36% | -21,5 -30,0 28.33% | -23,3 -22,0 -5.69% | -30,3 -24,2 -25.33% | -34,3 -31,9 -7.25% | -33,4 -34,0 1.61% | -37,0 | -42,0 | ||||
|
EBIT Million USD | Released Forecast Spread | -23,2 -31,0 25.14% | -27,2 -26,3 -3.49% | -29,6 -27,1 -9.09% | -21,6 -30,0 28.09% | -23,3 -23,1 -0.95% | -30,4 -25,6 -18.77% | -34,3 -31,3 -9.58% | -33,5 -32,4 -3.33% | -34,4 | -36,4 | -34,9 | -37,9 | -38,6 | -40,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,4 31.6% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.86% | -31,0 -29,5 -5.08% | -30,4 -31,1 2.34% | -33,5 | -35,7 | -34,2 | -35,9 | -37,1 | -39,3 |
|
Net income Million USD | Released Forecast Spread | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,8 32.63% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.86% | -31,0 -29,5 -5.08% | -30,4 -31,1 2.34% | -33,5 | -35,7 | -34,2 | -35,9 | -37,1 | -39,3 |
|
EPS USD | Released Forecast Spread | -0,57 -0,77 25.88% | -0,65 -0,65 0.4% | -0,70 -0,66 -5.6% | -0,49 -0,74 33.62% | -0,48 -0,51 6.18% | -0,49 -0,48 -1.13% | -0,56 -0,54 -4.37% | -0,54 -0,55 2.38% | -0,58 | 0,05 | -0,60 | -0,63 | -0,63 | -0,68 |
| Announcement Date | 08/11/22 | 09/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 11/03/24 | 08/05/24 | 06/08/24 | - | - | - | - | - | - |
More events
Past sector events for Olema Pharmaceuticals, Inc.
| 2024-09-09 16:01 | ABIVAX: Q2 2024 Earnings Release |
| 2024-09-05 02:00 | GENUS PLC: Q4 2024 Earnings Release |
| 2024-08-29 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q2 2024 Earnings Release |
| 2024-08-29 02:00 | BIOARCTIC AB: Q2 2024 Earnings Release |
| 2024-08-28 19:27 | MESOBLAST LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | R&G PHARMASTUDIES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-28 | MORPHOSYS AG: Q2 2024 Earnings Release |
| 2024-08-28 02:00 | PURETECH HEALTH PLC: Q2 2024 Earnings Release |
| 2024-08-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q2 2024 Earnings Release |
| 2024-08-27 04:00 | OCULIS HOLDING AG: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OLMA Stock
- Calendar Olema Pharmaceuticals, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition